Terbutaline (Bricanyl) in the treatment of female urge incontinence.
Fifteen women with idiopathic urge incontinence (8 motor and 7 sensory urge incontinence) were treated with a beta 2-adrenoceptor-stimulating agent, terbutaline (Bricanyl) for 3 months. A subjective effect on the symptoms urgency and frequency was found in 14 patients, and 12 patients (80%) became continent. In 6 of 8 cases the detrusor became stable. The drug was generally well tolerated; however, a high incidence of transient side effects were observed. Terbutaline seems to be valuable in the treatment of idiopathic female urge incontinence.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D013726:Terbutaline / Q000009:adverse effects / Q000627:therapeutic use*; D001743:Urinary Bladder / Q000187:drug effects; D014549:Urinary Incontinence / Q000188:drug therapy*; D014563:Urodynamics / Q000187:drug effects
D013726:Terbutaline